Shawn M. Talbott, Chief Science Officer at Lifevantage Corp (LFVN), bought 8,000 shares at $1.25 ($10K) on 2014-09-15, disclosed to the SEC on 2014-09-17.
Open-market purchase of $10k LFVN by Chief Science Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.